Mouth and throat cancer, called oropharynx cancer, used to be a disease seen
most commonly in elderly persons. Tobacco smoking and alcohol use were known to
be the leading causes of oropharyngeal cancer. Today, oral sex is listed as the
leading cause of cancer of the mouth and throat.
New research, published in the Journal of Clinical Oncology, demonstrates that
human papillomavirus, HPV, is the leading cause of cancer of the oropharnyx in
the U.S. The number of people diagnosed with HPV-related oral cancers in the
U.S. tripled from 1998 to 2004.
Currently, as NPR reports, almost 10,000 new cases of oral and throat cancer
are diagnosed each year, with a 28 percent increase in incidence since 1988.
Interestingly, the majority of those who are being diagnosed with the
HPV-related oropharyngeal cancers are men. This leads researchers to wonder if
the vaccine against HPV that is recommended for teenage girls may be affording
that gender with protection against oropharyngeal cancer, as well as the
currently known protection against cervical cancer.
Researchers have noted a marked drop in non-HPV-related mouth and throat
cancers since the American population has begun to turn away from tobacco
smoking.
The oropharyngeal cancer most commonly affects the tonsils, palate, base of the
tongue and the upper throat. Whereas this type of cancer was previously seen
most often in aged patients, it is now more common at younger ages, including
baby boomers and their juniors, reports Bloomberg News.
HPV is the most commonly transmitted sexual disease, but as Dr. Gregory
Masters, an oncologist at the Helen Graham Cancer Center in Delaware reminds
us, research is not yet clear that oral sex is the main or only transmission
factor in this cancer,
Dr. Maura Gillison, author of the research published in the Journal of Clinical
Oncology states that persons who have had six or more partners on whom they've
practiced unprotected oral sex are eight times more likely than those who have
not had oral sex to develop the HPV-related mouth and throat cancers, reports
CBS News.
Merck, the pharmaceutical company that manufactures the HPV vaccine, has issued
a statement that there are no current plans to research the usefulness of the
vaccine against oropharyngeal cancers.
Smack dab in the middle of the baby boomer generation , L.L. Woodard is a proud
resident of "The Red Man" state. With what he hopes is an everyman's view of
life's concerns both in his state and throughout the nation, Woodard presents
facts and opinions based on common-sense solutions.